Abstract: objective To report our experiences of implementing clinical pathway in hepatic cystic echinococcosis (HCE). Methods In our district echinococcosis fixed-point hospital, 120 operated patients with HCR were divided into a clinical pathway group (n=60) and a control group (n=60, non-implementation of clinical pathway. Days of hospital stay including days of preoperative preparation and postoperative recovery, and hospital costs including nation echinococcosis treatment project (NETP) actual expenses, reimbursement charges, number of zero pay and patients' satisfaction index of each group were followed-up and compared. Conclusion The implementation of HCE clinical pathway in our region can regulate patterns of diagnostic and treatment for HCE, reduce postoperative complications, shorten hospitalization time, reduce hospital cost, so is worthy of promotion.